YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Lyrica
Lyrica May Be Linked to Suicide
Keywords: Lyrica Suicide Side Effects Lawyer Lawsuit Neurontin
Lyrica & Neurontin AssociationLyrica (Generic: Pregabalin) is prescribed to patients for the management of neuropathic pain associated with diabetic peripheral neuropathy. Lyrica, manufactured by Pfizer, received FDA approval on December 30, 2004. Seizure patients also use Lyrica. Lyrica was manufactured as a substitute medication for Neurontin. Lyrica has only been tested and prescribed to adults 18 or older. Lyrica has not been studied in children under the age of 18. Lyrica, just like Neurontin, may cause increased risk of suicide and suicidal behavior.
Other Lyrica Side Effects
General side effects associated with Lyrica can include: dizziness, blurred vision, sleepiness, weight gain, swelling (edema), muscle problems, and altered perception. Weight gain is of particular concern to those with diabetes, as this can worsen their condition. Additional animal studies also found Lyrica to cause side effects in males. Lyrica lowered the fertility of some male animal subjects throughout testing. Males who received Lyrica who did reproduce had an increased risk of birth defects in their offspring.
Free Lawsuit Case Evaluation
If you or a loved one took Lyrica and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
LyricaRSS Feed
Pfizer Geodon Whistleblower Represented by Parker Waichman Alonso LLP
Sep 9, 2009 | Parker Waichman Alonso LLP
A whistleblower who was involved in last week's record breaking $2.3 billion Pfizer settlement was represented by the Great Neck, NY law firm of Parker Waichman Alonso LLP. The whistleblower lawsuit alleged that Pfizer illegally promoted the off-label use of the antipsychotic medication Geodon."We are proud of our client and the other relators who stepped forward to expose Pfizer's wrongdoing, and helped to make this settlement possible," said David Krangle, an attorney with Parker...
Pfizer's Illegal Promotion of Bextra and Other Drugs Results in Record Settlement, Guilty Plea
Sep 3, 2009 | Parker Waichman Alonso LLP
Pfizer Inc. and its subsidiary, Pharmacia & Upjohn Company Inc., have agreed to pay a record-setting $2.3 billion to settle claims arising from the illegal marketing of some drugs. According to a U.S. Department of Justice press release, Pharmacia & Upjohn Company has also agreed to plead guilty to a felony violation regarding off-label promotions of the painkiller Bextra. Bextra was withdrawn from the market in 2005.As we've reported previously, doctors may...
Baystate Medical Center Subpoenaed Over Fake Drug Studies
Apr 8, 2009 | Parker Waichman Alonso LLP
The Baystate Medical Center has received a subpoena as part of a federal investigation into a doctor there who falsified 21 drug studies. According to The Wall Street Journal, the U.S. Attorneys office in Boston is seeking financial records related to the work of Dr. Scott S. Reuben. As we reported last month, medical journals have been asked to retract studies involving Vioxx, Celebrex, Lyrica and other drugs. All of the studies were published between 1996 and 2008. According...
Researcher Faked Data for 21 Studies Involving Vioxx, Celebrex and Other Drugs
Mar 11, 2009 | Parker Waichman Alonso LLP
Medical journals have been asked to retract 21 studies that touted the benefits of Vioxx, Celebrex and other drugs. According to The Wall Street Journal, Baystate Medical Center, Springfield, Mass. is asking the journals to make the retractions because its former chief of acute pain, Dr. Scott S. Reuben, had faked data used in the studies.In addition to Vioxx and Celebrex, some of the 21 studies involved the fibromyalgia drug Lyrica and the antidepressant Effexor XR. Reuben's...
Lyrica, Cymbalta Fibromyalgia Promotions Questioned
Feb 9, 2009 | Parker Waichman Alonso LLP
Two drug makers are spending a fortune to promote medications for a disease that some doctors say may not even exist. According to the Associated Press, Eli Lilly and Pfizer have donated more than $6 million to nonprofit groups to spread information about fibromyalgia in an effort to boost sales of Cymbalta and Lyrica.Fibromyalgia, defined as a chronic, widespread pain condition of unknown origin, is a controversial diagnosis. No biological tests exist to diagnose...
Lyrica
Quick Facts
Lyrica Reference Guide
Generic Name
Pregabalin
Date Approved
December 30, 2004
Manufacturer
Pfizer
Status
On the market
Approved Uses
Diabetic peripheral neuropathy
Seizures
Serious Side Effects
Suicide
Suicidal behavior
Death Related Topics
Neurontin
Diabetes
Defective Drugs
Diseases
Pregabalin
Date Approved
December 30, 2004
Manufacturer
Pfizer
Status
On the market
Approved Uses
Diabetic peripheral neuropathy
Seizures
Serious Side Effects
Suicide
Suicidal behavior
Death Related Topics
Neurontin
Diabetes
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS